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Abstract 
 
Cocoa is a rich source of fiber and flavonoids with recognized antioxidant and anti-
inflammatory potential. The aim of this study was to evaluate the effects of a cocoa-enriched 
diet on rats with dextran sulphate sodium (DSS)-induced colitis. Wistar rats were fed with 
either a 5% cocoa diet or standard diet. Colon inflammation was induced by DSS in the 
drinking water: 5% for 6 days and 2% over the following 9 days. Colitis was assessed by 
body weight loss, stool consistency and blood presence in stools. A group of animals fed 
standard diet was treated with quercitrin (1 mg/kg) after colitis establishment. After 2 weeks 
of DSS treatment, the colon oxidative and inflammatory status and lymphocyte composition 
from blood and mesenteric lymph nodes (MLN) were assessed. The cocoa-fed group did not 
exhibit amelioration of clinical colitis but displayed higher antioxidant activity than the 
colitic reference group by the restoration of colon glutathione content and prevention of lipid 
peroxidation. The cocoa diet showed anti-inflammatory potential because it down-regulated 
serum TNF-α, colon iNOS activity and decreased colon cell infiltration. Lymphocyte 
composition in MLN was not modified by drinking DSS, but there was an increase in the 
proportion of NK and regulatory T cells in the blood. These changes were not modified by 
cocoa. In conclusion, cocoa intake may help to inhibit the negative oxidative effects 
consequent to colitis, although this action is not enough to abrogate the intestinal 
inflammation significantly. 
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Introduction 
 
Ulcerative colitis (UC) and Crohn’s disease (CD) constitute the principal forms of chronic 
inflammatory bowel disease (IBD). Although the exact etiology of both CD and UC remains 
unclear, IBD inflammation is thought to result from a complex interaction of genetic and 
environmental factors that leads to altered immunologic responses to gut microbiota1.  
 
Current treatments for IBD include immunosuppressant or biological drugs blocking key 
molecules of the inflammatory cascade. However, significant side effects have been reported 
thereby limiting their use2. Because of this, the use of complementary or alternative 
interventions is becoming widespread and an increasing number of studies show the potential 
of biologically active nutrients, which may play an important role in the immune response 
modulation of IBD3. In this context, since the colon may be subjected to oxidative stress 
during active inflammation, the incorporation of dietary antioxidants might help to reduce 
mucosal inflammation4. Commonly occurring dietary polyphenols, particularly flavonoids, 
have been reported to possess remarkable antioxidant and anti-inflammatory capability in 
experimental conditions5,6. Cocoa and cocoa-based products are natural sources of flavan-3-
ols such as (-)-epicatechin, (+)-catechin and their oligomers, the procyanidins7. Moreover, 
cocoa is considered an excellent source of dietary fiber, which retains significant amounts of 
polyphenolic compounds and plays a key role in their transportation through the 
gastrointestinal tract8. Cocoa procyanidins seem to reach the colon intact where they are 
metabolized by the intestinal microbiota into various phenolic acids9. Several studies have 
demonstrated the antioxidant capacity of cocoa flavonoids and their metabolites10. In 
addition, cocoa has exhibited in vitro and in vivo anti-inflammatory and regulatory effects on 
immune cells involved in innate and acquired immunity11-13. 
 
As the oral administration of dextran sulphate sodium (DSS) is a widely used and well-
characterized model of colitis in rodents and shares clinical and pathological characteristics 
with human IBD14, the aim of this study was to evaluate the effects of a diet containing cocoa 
on DSS-induced chronic colitis in rats. In particular, we focused on the response of 
mesenteric lymph nodes and blood lymphocytes and on the assessment of diverse 
biochemical variables associated with colonic oxidative stress induced by DSS-induced 
colitis. In addition, the effects of cocoa were compared with those exerted by quercitrin, a 
glycoside of the flavonoid quercetin with recognized anti-inflammatory activity in the DSS 
model6 which was used as a control treatment. 
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Materials and methods 
Reagents  
Dextran sulphate sodium (DSS) of molecular weight 36-50 kDa was obtained from MP 
Biomedicals (Illkirch, France). RPMI 1640 medium, glutamine, penicillin, streptomycin, and 
fetal bovine serum (FBS) were purchased from PAA (Pasching, Austria). Quercitrin was 
obtained from Extrasynthèse (Genay, France). Defatted Natural Forastero cocoa containing 
21.85 mg/g polyphenols (Table 1) was provided by Nutrexpa SL (Barcelona, Spain). All 
other reagents, unless otherwise stated, were purchased from Sigma-Aldrich (Madrid, Spain).  
 
Table 1. Polyphenol composition of the cocoa used in the study. Individual phenolic 
compounds and total phenolic content in cocoa powder were determined by HPLC and the 
Folin-Ciocalteu method respectively, as previously described15. 
 
Compound mg/g
Procyanidin B2 1.487 
Catechin 0.740 
Epicatechin 1.917 
Isoquercitin 0.053 
Quercitin 0.020 
Total polyphenols 21.85 
 
 
 
Animals and diets 
Five-week-old female Wistar rats (Harlan, Barcelona, Spain) were housed in cages under 
controlled conditions of temperature (22±2 ºC) and humidity in a 12:12 light-dark cycle. All 
experimental procedures were reviewed and approved by the Ethical Committee for Animal 
Experimentation of the University of Barcelona (reference DMAH3874). 
 
Animals had free access to water and chow. The AIN-93M formulation16 was used as the 
standard diet. A diet containing 50 g/kg cocoa was produced from a modification of the AIN-
93M formula as previously described12 and was provided for 3 weeks prior to DSS 
administration and until the end of the study (Figure 1). 
 
Induction and assessment of colitis  
Colitis was induced by ad libitum administration of 5% DSS (w/v) in drinking water for 6 
days and 2% DSS for the following 9 days. Animals were randomly assigned to four 
experimental groups (n=12/group; Figure 1): a group receiving a standard diet and water 
without DSS (REF); a group fed the standard diet and water with DSS (DSS); a group fed the 
standard diet and water with DSS that was treated daily with quercitrin (1 mg/kg, p.o.) from 
the day that the DSS dose was reduced to 2% (DSS-Q); and a group fed the cocoa diet from 
three weeks prior to DSS drinking and until the end of the study (DSS-C). The dosing 
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protocol for quercitrin was established according to reported studies showing an amelioration 
of the DSS-induced inflammatory process6.  
Clinical assessment of colitis included daily evaluation of body weight, stool consistency 
(normal, loose or diarrhea), and presence of macroscopic blood in the stools. These variables 
allowed calculating a disease activity index (DAI) with a 0 to 4 point severity scale17. At the 
end of the study (Figure 1), animals were anesthetized intramuscularly with ketamine (90 
mg/kg) and xylazine (10 mg/kg). Blood, mesenteric lymph nodes (MLNs), small intestine 
and colon were obtained from each animal. 
 
 Figure 1. Experimental design: three groups (Reference -REF-, DSS and DSS-Quercitrin       
-DSS-Q-) were fed a standard diet, and a group (DSS-C) was fed a cocoa diet throughout the 
study from three weeks before colitis induction. DSS was incorporated into the drinking 
water at 5% and 2% over 6 and 9 days, respectively. Quercitrin was administered by oral 
route (1 mg/kg/day) to the DSS-Q group from day 6. 
 
 
Mesenteric lymph node and blood lymphocyte phenotype 
MLNs and blood lymphocytes were isolated as previously described12. Lymphocyte 
phenotype was determined by three-color immunofluorescence staining and flow cytometry 
analysis. Mouse anti-rat monoclonal antibodies (MAb) used here included: fluorescein 
isothiocyanate (FITC)-conjugated anti-T-cell-receptor (TCR) αβ (R73), CD45RA (OX-33), 
CD4 (OX-35) and CD25 (IL-2Rα chain OX-39) MAb; phycoerythrin (PE)-conjugated anti-
CD4 (OX-35) and NKR-P1A (10/78) MAb; peridinin-chlorophyll-protein (PerCP)-
conjugated anti-CD8α (OX-8) MAb (all from BD Biosciences); allophycocyanin (APC)-
conjugated anti-Foxp3 (FJK-16a) MAb (eBioscience, Frankfurt, Germany).  
 
Extracellular and intracellular staining was carried out as in previous studies12. Flow 
cytometry analysis was performed on a Cytomics FC500-MPL cytometer (Beckman Coulter, 
Miami, FL, USA) and data were analyzed by the software Summit V3.1 (Cytomation, Fort 
Collins, CO, USA). Lymphocyte subsets were defined as B (CD45RA+), Th 
(CD4+TCRαβ+), Tc (TCRαβ+CD8α+), activated Th (Tact; CD4+CD25+Foxp3-), and 
regulatory Th (Treg; CD4+CD25+Foxp3+). Results are expressed as a percentage of positive 
cells in the total lymphocyte population or, in some cases, are shown as a percentage of 
positive cells in a specific lymphocyte subset (Tact and Treg in Th cells). 
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Blood leukocyte counts  
Total white blood cell counts were determined automatically by means of a Coulter Counter 
JT hemocytometer (Beckman Coulter) calibrated for rat samples. Differential leukocyte 
counts were microscopically established in blood smears stained using the May-Grünwald-
Giemsa technique.  
 
Quantification of TNF-α  
Serum TNF-α concentration was quantified using a commercial rat cytokine bead 
immunoassay (Bender MedSystems GmbH, Vienna, Austria) following manufacturer’s 
recommendations. Analysis was performed using a Cytomics FC500-MPL cytometer 
(Beckman Coulter) and the FlowCytomix Pro2.2.1 program from Bender MedSystems 
GmbH. 
 
Quantification of S-Ig in small intestine  
The small intestine was excised and carefully rinsed with ice-cold PBS. The distal half of the 
small intestine was used to obtain the gut wash for S-IgA and S-IgM quantification by 
ELISA12. 
 
Assessment of the inflammatory and oxidative status of the colon  
The colon was excised and carefully rinsed with ice-cold PBS. The total weight and length of 
the colon were determined to establish intestinal wall thickening and colon shortening, 
respectively. Thereafter, the colon was opened longitudinally and a transverse section of the 
damaged distal area was kept for histological analysis. The remaining colon was divided into 
four longitudinal strips that were immediately frozen in liquid N2 and stored at -80 ºC to 
estimate some inflammatory mediators such as prostaglandin E2 (PGE2), leukotriene B4 
(LTB4) and inducible nitric oxide synthase activity (iNOS). Thiobarbituric acid reactive 
substance (TBARS) and total glutathione (GSH) content were measured as antioxidant 
indicators. 
 
A longitudinal colon stripe from each animal was homogenized in 0.1 M sodium phosphate 
buffer pH 7.4 (200 g/L) containing 1 mM EDTA and 10 μM indomethacin. PGE2 and LTB4 
concentrations were measured in diluted samples (1:10) using enzyme immunoassay kits 
(Cayman Chemicals, Tallinn, Estonia) according to manufacturer’s recommendations. 
Results were expressed as ng/g of wet tissue. 
 
iNOS activity was measured using a commercial kit (Cayman Chemicals). For this purpose, a 
second longitudinal colon stripe from each animal was homogenized in the buffer sample 
provided by the kit, and the assay was performed following manufacturer’s instructions. Data 
were expressed as a conversion percentage of [3H] arginine to [3H] citrulline.  
 
A third longitudinal colon stripe from each animal was homogenized in 1.15% KCl buffer 
containing 1% (v/v) butylhydroxytoluene (BHT) at 100 g/L. TBARS concentration was 
determined as an index of lipid peroxidation, a major indicator of oxidative stress. 
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Malondialdehyde (MDA) was used as standard curve. Data were expressed as μmol MDA /g 
of wet tissue. 
A fourth longitudinal colon stripe from each animal was deproteinized by homogenization 
with 5% trichloroacetic acid in sodium phosphate buffer pH 6.0 (50 g/L), and followed by 3 
repeated freeze–thaw cycles. GSH content was quantified using the 5,5′-dithio-bis 2-
nitrobenzoic acid (DTNB) recycling assay18. DTNB was used as standard and data were 
expressed as μmol/g of wet tissue. 
 
Histological analysis 
Colon segments were fixed in 10% buffered formaldehyde. Tissue samples were washed with 
tap water, dehydrated in increasing concentrations of ethanol (70% for 1 h, 96% for 1 h x3) 
and embedded in paraffin. Tissue sections were cut (4 μm) on a microtome (Leitz, Wetzlar, 
Germany) and stained with the hematoxylin-eosin technique. Histological assessment was 
carried out in a blind fashion considering cell infiltration and goblet cell lost together with 
structural changes. Microphotographs were taken with an Olympus BX41 microscope 
(Olympus, Hamburg, Germany). 
 
Statistical analysis  
The software package SPSS 16.0 (SPSS, Inc., Chicago, IL, USA) was used for statistical 
analysis. Data were analyzed using a one-way analysis of variance (ANOVA) followed by 
the Scheffé’s post-hoc significance test after having confirmed normality and equal variance 
assumptions by the Kolmogorov-Smirnov’s and Levene’s statistical tests, respectively. 
Differences were considered statistically significant at P values of < 0.05.  
 
 
Results 
Effects of cocoa diet on clinical signs of colitis  
Rats receiving DSS developed colitis, which was assessed by the disease activity index (DAI, 
Figure 2). DAI increased during the first 6 days, remained stable for the following three days 
and decreased from day 9. No significant differences were observed among DSS-C, DSS-Q 
and DSS groups.  
 
Figure 2. Clinical time course of DSS-induced colitis. Disease activity index (DAI) was 
calculated by assessment of body weight, stool consistency and presence of blood in the 
stools for each animal, using a 0 to 4 severity scale. Values are means, with their standard 
errors represented by vertical bars (n=12). –●–, Reference; –○–, DSS; –▲–, DSS- Quercitrin; 
–∆–, DSS-Cocoa. 
 8 
Effects of cocoa diet on colon architecture after receiving DSS  
The analysis of the intestine after 14 days of DSS treatment revealed a higher weight and a 
shorter length of the colon in the DSS, DSS-Q and DSS-C groups in comparison with that of 
the REF group. In consequence, the colon weight/length ratio was significantly increased in 
the three groups (P < 0.05; Figure 3a) without significant differences among them. The cocoa 
diet and the quercitrin treatment did not prevent the changes induced by DSS in the colon 
architecture. However, the microscopic analysis of the colon sections from animals of the 
DSS-Q and DSS-C groups showed only a moderate lamina propria mononuclear cell 
infiltration and the prevention of goblet cell loss in comparison with the DSS group (Figure 
3b-3e).  
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Figure 3. Colon architecture after DSS treatment. Colon weight/length ratio (a): Values are 
means, with their standard errors represented by vertical bars (n=12). * Mean values were 
significantly different from those of the reference (REF) group (P<0.05; ANOVA followed 
Scheffé’s post-hoc significance test). Micrographs showing histological sections of colonic 
mucosa at the end of the study from a representative REF rat (b), a DSS control rat (c), a 
quercitrin-treated rat (d) and a cocoa-fed rat (e) (Scale bar corresponds to 200 μm). 
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Continuous arrows indicate presence of either goblet cells (GC) or cell infiltration (CI), and 
discontinuous arrows indicate their absence.  
 
 
Effects of cocoa diet on inflammatory and oxidant indicators from blood and colon  
After 14 days of DSS treatment, the colonic inflammatory process was reflected by a marked 
leukocytosis in the DSS, DSS-Q and DSS-C groups when compared with the REF group 
(P < 0.05; Figure 4a). This increase was due to both neutrophil and lymphocyte counts 
(Figure 4b and 4c), which were significantly higher in the DSS group than in the REF group 
(P < 0.05) and showed the same increased pattern in animals fed cocoa diet. The leukocytosis 
in the DSS-Q group was mainly attributed to increased neutrophil counts since lymphocyte 
counts were similar to those found in the REF group. 
 
 
Figure 4. Blood leukocyte counts after DSS treatment. Number of total leukocytes (a), 
neutrophils (b) and lymphocytes (c). Values are means, with their standard errors represented 
by vertical bars (n=12). *Mean values were significantly different from those of the reference 
(REF) group (P<0.05; ANOVA followed Scheffé’s post-hoc significance test). 
 
 
 
Serum TNF-α concentration significantly increased in the DSS group compared to REF 
animals after 14 days of DSS drinking (P < 0.05; Table 2). Similar results were obtained in 
the DSS-Q group, which was treated with quercitrin. Interestingly, serum TNF-α increase 
was significantly prevented by the cocoa diet (P < 0.05). 
 
The inflammatory response was also studied in colon homogenates by means of PGE2 and 
LTB4 concentrations and iNOS activity (Table 2). PGE2 concentration was higher in the DSS 
group (P < 0.05) than in the REF group, and neither the cocoa diet nor the quercitrin 
treatment prevented such increase. Similarly, LTB4 concentration was increased in the DSS 
group compared to REF animals and no effect was detected in the cocoa diet group. 
However, quercitrin treatment tended to decrease the LTB4 concentration. On the other hand, 
colon iNOS activity was slightly increased in the DSS and DSS-Q groups compared to that of 
the REF group, but, interestingly, cocoa-fed animals inhibited iNOS activity in the colon that 
was even lower than in the REF animals (P < 0.05).  
 
With regard to oxidative status in the colon, we determined TBARS as a measure of lipid 
peroxidation and GSH content as an endogenous antioxidant. Both the quercitrin treatment 
and the cocoa diet tended to reduce the TBARS produced in the DSS group (Table 2). GSH 
content was significantly decreased in the DSS group compared to the REF group (P < 0.05). 
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The cocoa diet increased the colon GSH content (P < 0.05 vs. DSS group), which was even 
higher than in the REF group. GSH content in the DSS-Q group was between that observed 
in the DSS and REF animals. 
 
 
Table 2. Inflammatory and oxidative status indicators in serum and colon specimens of 
studied groups.  
 
PGE2, prostaglandin E2; LTB4, leukotriene B4; iNOS, inducible nitric oxide synthase activity; 
TBARS, thiobarbituric acid reactive substance; GSH, total glutathione; REF, reference; DSS, 
dextran sulphate sodium; Q, quercitrin; C, cocoa. 
Data are expressed as mean ± SD, n=12.  
*P < 0.05 versus the REF group; †P < 0.05 versus the DSS group 
 
 
Effects of cocoa diet on MLN and blood lymphocyte composition  
In MLN, the colon inflammation in the DSS group did not modify the percentage of Th, Tc, 
B, NK, NKT, Treg and Tact lymphocytes compared to the REF group (Figure 5a-5c). However, 
both the quercitrin-treated and cocoa-fed groups displayed a lower Th cell percentage than 
the REF group (P < 0.05), and the DSS-C group showed a higher B cell proportion (P < 0.05) 
than the REF group. 
 
In the blood, DSS administration did not significantly alter the proportion of Th, Tc and B 
cells (Figure 5d) but did increase the percentages of NK and Treg cells, which were higher in 
the three DSS groups than in the REF group (P < 0.05, Figure 5e and 5f). The DSS-Q group 
showed the highest Treg proportion in Th and both the DSS-Q and DSS-C groups increased 
the proportion of Tact subset in Th cells (P < 0.05). 
 
Effect of cocoa diet on small intestine S-IgA and S-IgM content  
In the DSS group, the S-IgA content in the small intestine wash was not modified by the 
inflammatory process (Figure 6), although there was a reduction in the S-IgM content 
compared to the REF animals (P < 0.05). This reduction was not observed in animals treated 
with quercitrin. The cocoa diet significantly reduced the amount of both S-IgA and S-IgM in 
the small intestine wash (P < 0.05) in comparison with the REF and the DSS groups. 
 
 
 REF  DSS  DSS-Q  DSS-C  
serum TNF-α (pg/mL) 13.4 ± 0.6 19.3 ± 1.8* 18.9 ± 1.8* 8.4 ± 1.0*† 
colon PGE2 (ng/g) 29.03 ± 3.95 46.14 ± 14.36* 58.75 ± 9.29* 49.31 ± 7.77* 
colon LTB4 (ng/g) 0.49 ± 0.07 0.68 ± 0.08* 0.59 ± 0.19 0.64 ± 0.13 
colon iNOS (%) 16.40 ± 1.84 18.90 ± 2.99 17.00 ± 2.03 11.5 ± 1.75*† 
colon TBARS (μmol MDA/g) 2.12 ± 0.24 2.82 ± 0.44* 1.97 ± 0.27 2.26 ± 0.44 
colon GSH (μmol/g) 0.96 ± 0.08 0.72 ± 0.06* 0.89 ± 0.12 1.05 ± 0.16† 
 11 
 
Figure 5. MLN (a-c) and blood (d-f) lymphocyte composition after DSS treatment. 
Percentages of Th, Tc and B cells (a and d), NK and NKT subsets (b and e), Treg and Tact 
cells in Th subset (c and f). Values are means, with their standard errors represented by 
vertical bars (n=12). *Mean values were significantly different from those of the reference 
(REF) (□) group (P<0.05; ANOVA followed Scheffé’s post-hoc significance test). †Mean 
values were significantly different from those of the DSS (■) group (P<0.05; ANOVA 
followed Scheffé’s post-hoc significance test). ■, DSS-Quercitrin group; ■, DSS-Cocoa 
group. 
 
 
 
Figure 6. S-IgA and S-IgM concentrations in the small gut wash. Values are means, with 
their standard errors represented by vertical bars (n=12). *Mean values were significantly 
different from those of the reference (REF) (□) group (P<0.05; ANOVA followed Scheffé’s 
post-hoc significance test). † Mean values were significantly different from those of the DSS 
(■) group (P<0.05; ANOVA followed Scheffé’s post-hoc significance test). ■, DSS-
Quercitrin group; ■, DSS-Cocoa group.  
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Discussion  
This paper assesses the impact of a dietary intervention with cocoa, as a source of antioxidant 
flavonoids, on the DSS model of rat colitis. In particular, we focused on the intestinal and 
systemic inflammatory response, including the oxidative status of rats fed cocoa. Cocoa diet 
has been reported to show anti-inflammatory and immunomodulatory properties11-13 but there 
is a scarce number of studies describing the effects of cocoa on IBD. The effects observed 
were compared with those exerted by quercitrin, with recognized antioxidant and anti-
inflammatory properties6. The results demonstrate that, in our experimental conditions, cocoa 
intake and quercitrin treatment do not improve clinical colitis although they certainly 
contributed to reducing colonic oxidative activity and tissue damage. Moreover, cocoa 
showed anti-inflammatory potential by down-regulating serum TNF-α concentration and 
colon iNOS activity and by decreasing colon cell infiltration. 
 
The pathogenesis of IBD involves the recruitment of leukocytes into the intestinal mucosa19. 
Among them, macrophages secrete large amounts of inflammatory mediators and nitrogen 
and reactive oxygen species that induce oxidative stress19. In this line, we found that DSS-
induced colitis produced consumption of glutathione and an increased lipid peroxidation in 
the colon. The cocoa diet avoided the glutathione consumption and partially prevented the 
lipid peroxidation. Similar results were obtained by quercitrin treatment although neither the 
cocoa diet nor the quercitrin treatment reduced the clinical development of colitis. In 
agreement with our results, the antioxidant luteolin incorporated into the diet does not 
ameliorate and even worsens the DSS-induced colitis in NF-κBEGFP transgenic mice20. 
Moreover, consumption of a lemon verbena infusion rich in polyphenolic compounds does 
not improve the histopathological changes induced by 4% DSS  in rats, despite stimulating 
the activity of the antioxidant enzyme superoxide dismutase and reducing lipid peroxidation 
in the colon21. However, it has been recently reported that a polyphenol-enriched cocoa 
extract is able to decrease acute DSS colitis in mice22, thus evidencing the promising anti-
inflammatory effects of cocoa flavonoids. These results may also suggest that we did not 
observe a clear colitis reduction because of the lower polyphenol content in the cocoa that we 
used. 
 
On the other hand, as we have confirmed here, colitis is associated with increases in the 
inflammatory mediators LTB4 and PGE223. However, neither cocoa nor quercitrin treatment 
could avoid such increases. Another indicator of the inflammatory process in the colon and 
macrophage infiltrates is the iNOS activity6. Although we found no higher iNOS activity in 
animals receiving DSS, interestingly, the cocoa-fed group showed lower iNOS activity than 
the DSS group. Similarly, cocoa diet prevented the increase in serum TNF-α concentration, a 
key molecule in IBD pathogenesis24. Both protective effects on iNOS and TNF-α are in line 
with previous in vitro and in vivo studies11,25, but they could not contribute to attenuate the 
intestinal inflammatory process. 
 
In order to assess the effects of cocoa on the inflammatory process beyond the colon, cell 
composition was established in the blood and MLN. There is limited information about the 
impact of DSS on the cell populations of these compartments in rat. In our study, the 
inflammatory process did not vary the proportion of Th, Tc, B, NK, NKT, Treg and Tact 
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lymphocytes in MLN. However, the cocoa diet increased the proportion of B lymphocytes, 
and both the cocoa diet and the quercitrin treatment reduced the proportion of Th cells in 
MLN. The results from the cocoa intake by the colitic animals are in line with the effects 
observed in the MLN of cocoa-fed healthy animals13. In any case, the decrease of the 
proportion of Th cells did not involve clinical recovery, which could be attributed to the fact 
that Th or B cells may not be essential in DSS colitis, as shown in immunodeficient mice26. 
On the other hand, we found no significant changes in the MLN percentage of Treg cells, 
contrary to recent studies showing a decrease of Treg subset in the MLN of mice that received 
5% DSS in their drink for 7 days27.  
In the blood compartment, we found that the intestinal inflammatory process produced 
neutrophilia and lymphocytosis but the proportions of the main lymphocyte subsets were not 
modified. However, the NK cell percentage increased in the blood of the DSS animals. This 
finding is consistent with the fact that depletion of NK cells attenuates the severity of acute 
colitis in DSS-treated mice28 and suggests an important role of these cells in colitis. Neither 
the cocoa diet nor the quercitrin treatment prevented the increase of the blood NK cell 
proportion, which could be one of the reasons why cocoa-fed animals did not display colitis 
amelioration in spite of showing antioxidant activity in the colon and reduced serum TNF-α. 
Regarding the Treg subpopulation, the inflammatory process unexpectedly increased the 
percentage of Treg cells in Th lymphocytes in the blood. The Treg increase might be seen as an 
attempt to re-establish intestinal homeostasis under inflammatory conditions.  
 
Although the exact mechanism through which DSS initiates colitis remains unknown, 
different studies suggest that DSS administration may compromise the gut epithelial barrier 
function resulting in an increased permeability14. The mucosal IgA system contributes to the 
barrier functionality generating immune protection in a non-inflammatory manner. The cocoa 
diet significantly decreased the S-IgA and S-IgM in the small gut as previously reported in 
healthy animals13. Although in our study the colonic S-IgA concentration was not assessed, 
the down-regulatory effect on S-IgA of small intestine may have also occurred in the colon of 
cocoa-fed animals. In fact, previous studies have reported decreased S-IgA concentration in 
the faces of healthy animals fed with a diet containing 5% of cocoa29. Therefore, it could be 
suggested that the cocoa diet, although exerting antioxidant and even anti-inflammatory 
protection, may increase colon permeability by reducing S-IgA content, which may 
contribute to the inflammatory process. In other words, those beneficial effects of cocoa 
flavonoids may have been counteracted by a decreased S-IgA protection in the colon. 
 
In conclusion, a diet containing cocoa may help to manage the oxidative stress consequent to 
colitis, although this action is not enough to reverse the inflammatory process. Cocoa intake 
shows anti-inflammatory potential and seems to decrease colon cell infiltration. Therefore, 
cocoa diet may be considered as a promising complementary therapy for IBD. 
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